186
Views
5
CrossRef citations to date
0
Altmetric
Research Article

N-acetylcysteine potentiates diclofenac toxicity in Saccharomyces cerevisiae: stronger potentiation in ABC transporter mutant strains

ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon
Pages 89-94 | Received 06 Sep 2016, Accepted 08 Apr 2017, Published online: 15 May 2017

References

  • Al-Attrache, H., et al., 2016. Differential sensitivity of metabolically competent and non-competent HepaRG cells to apoptosis induced by diclofenac combined or not with TNF-α. Toxicology Letters, 258, 71–86.
  • Banks, A.T., et al., 1995. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology, 22, 820–827.
  • Boelsterli, U.A., 2003. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicology and Applied Pharmacology, 192, 307–322.
  • Bort, R., et al., 1999. Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. The Journal of Pharmacology and Experimental Therapeutics, 288, 65–72.
  • Breen, E.G., et al., 1986. Fatal hepatitis associated with diclofenac. Gut, 27, 1390–1393.
  • Chant, J., 1999. Cell polarity in yeast. Annual Review of Cell and Developmental Biology, 15, 365–391.
  • Deffieu, M., et al., 2009. Glutathione participates in the regulation of mitophagy in yeast. The Journal of Biological Chemistry, 284, 14828–14837.
  • Edlundh-Rose, E., et al., 2005. Gene expression analysis of human epidermal keratinocytes after N-acetyl L-cysteine treatment demonstrates cell cycle arrest and increased differentiation. Pathobiology: journal of Immunopathology, Molecular and Cellular Biology, 72, 203–212.
  • Efrati, S., et al., 2007. N-acetylcysteine attenuates NSAID-induced rat renal failure by restoring intrarenal prostaglandin synthesis. Nephrology, Dialysis, Transplantation: official Publication of the European Dialysis and Transplant Association – European Renal Association, 22, 1873–1881.
  • Egner, R., et al., 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Molecular Biology of the Cell, 9, 523–543.
  • Fredriksson, L., et al., 2011. Diclofenac inhibits tumor necrosis factor-alpha-induced nuclear factor-kappaB activation causing synergistic hepatocyte apoptosis. Hepatology, 53, 2027–2041.
  • Fredriksson, L., et al., 2014. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFalpha-mediated hepatotoxicity. Toxicological Sciences: An Official Journal of the Society of Toxicology, 140, 144–159.
  • Ghalehnoo, Z.R., et al., 2010. The role of diclofenac sodium in the dimorphic transition in Candida albicans. Microbial Pathogenesis, 48, 110–115.
  • Gomez-Lechon, M.J., et al., 2003. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochemical Pharmacology, 66, 2155–2167.
  • Gutierrez-Correa, J., and Stoppani, A.O., 1997. Inactivation of yeast glutathione reductase by Fenton systems: effect of metal chelators, catecholamines and thiol compounds. Free Radical Research, 27, 543–555.
  • Hancock, J.T., Desikan, R., and Neill, S.J., 2001. Role of reactive oxygen species in cell signalling pathways. Biochemical Society Transactions, 29, 345–350.
  • Hou, Y., et al., 2015. N-acetylcysteine and intestinal health: a focus on its mechanism of action. Frontiers in Bioscience (Landmark Ed), 20, 872–891.
  • Inoue, A., et al., 2004. Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome and caspase pathway. Free Radical Biology & Medicine, 37, 1290–1299.
  • Kelly, G.S., 1998. Clinical applications of N-acetylcysteine. Alternative Medicine Review: a Journal of Clinical Therapeutic, 3, 114–127.
  • Koppen, A., et al., 2014. Recommendations for the paracetamol treatment nomogram and side effects of N-acetylcysteine. The Netherlands Journal of Medicine, 72, 251–257.
  • Kretz-Rommel, A., and Boelsterli, U.A., 1993. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicology and Applied Pharmacology, 120, 155–161.
  • Kuge, S., and Jones, N., 1994. YAP1 dependent activation of TRX2 is essential for the response of Saccharomyces Cerevisiae to oxidative stress by hydroperoxides. The EMBO Journal, 13(3), 655–664.
  • Lim, M.S., et al., 2006. Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes. Toxicology and Applied Pharmacology, 217, 322–331.
  • Maiuri, A.R., et al., 2015. Cytotoxic synergy between cytokines and NSAIDs associated with idiosyncratic hepatotoxicity is driven by mitogen-activated protein kinases. Toxicological Sciences: An Official Journal of the Society of Toxicology, 146, 265–280.
  • Masubuchi, Y., Nakayama, S., and Horie, T., 2002. Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology, 35, 544–551.
  • Morioka, N., et al., 2004. Nonsteroidal anti-inflammatory drugs potentiate 1-methyl-4-phenylpyridinium (MPP+)-induced cell death by promoting the intracellular accumulation of MPP + in PC12 cells. The Journal of Pharmacology and Experimental Therapeutics, 310, 800–807.
  • Mulhall, K.J., Curtin, W.A., and Given, H.F., 2003. Comparison of different anti-inflammatory agents in suppressing the monocyte response to orthopedic particles. Orthopedics, 26, 1219–1223.
  • Pagant, S., et al., 2008. Mapping of interdomain interfaces required for the functional architecture of Yor1p, a eukaryotic ATP-binding cassette (ABC) transporter. The Journal of Biological Chemistry, 283, 26444–26451.
  • Parasassi, T., et al., 2005. Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms. Cell Death and Differentiation, 12, 1285–1296.
  • Parasassi, T., et al., 2010. Thiol redox transitions in cell signaling: a lesson from N-acetylcysteine. The Scientific World Journal, 10, 1192–1202.
  • Piecuch, A., and Oblak, E., 2014. Yeast ABC proteins involved in multidrug resistance. Cell. Mol. Biol. Lett, 19, 1–22.
  • Ramudo, L., and Manso, M.A., 2010. N-acetylcysteine in acute pancreatitis. World Journal of Gastrointestinal Pharmacology and Therapeutics, 1, 21–26.
  • Rushworth, G.F., and Megson, I.L., 2014. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacology & Therapeutics, 141, 150–159.
  • Samuni, Y., et al., 2013. The chemistry and biological activities of N-acetylcysteine. Biochimica et Biophysica Acta, 1830, 4117–4129.
  • van Leeuwen, J.S., et al., 2011a. Subunits Rip1p and Cox9p of the respiratory chain contribute to diclofenac-induced mitochondrial dysfunction. Microbiology, 157, 685–694.
  • van Leeuwen, J.S., Vermeulen, N.P., and Vos, J.C., 2011b. Involvement of the pleiotropic drug resistance response, protein kinase C signaling, and altered zinc homeostasis in resistance of Saccharomyces cerevisiae to diclofenac. Applied and Environmental Microbiology, 77, 5973–5980.
  • van Leeuwen, J.S., et al., 2011c. Metabolism related toxicity of diclofenac in yeast as model system. Toxicology Letters, 200, 162–168.
  • Vernhet, L., et al., 2003. Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons. The Journal of Pharmacology and Experimental Therapeutics, 304, 145–155.
  • Wang, A.G., et al., 2004. Effects of phenobarbital on metabolism and toxicity of diclofenac sodium in rat hepatocytes in vitro. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 42, 1647–1653.
  • Watanabe, N., et al., 2007. Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis. Hepatology Research: The Official Journal of the Japan Society of Hepatology, 37, 598–607.
  • Xu, Y.C., et al., 2002. Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. The Journal of Biological Chemistry, 277, 28051–28057.
  • Zafarullah, M., et al., 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences, 60, 6–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.